Sign In

Login

Password

Forgot Password ? Sign Up

Силмитасертиб (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Силмитасертиб" in Russian language version.

refsWebsite
Global rank Russian rank
5doi.org
2nd place
3rd place
5nih.gov
4th place
6th place
1forbes.ru
885th place
51st place
1web.archive.org
1st place
1st place

doi.org (Global: 2nd place; Russian: 3rd place)

dx.doi.org

  • Pierre F, Chua PC, O'Brien SE, Siddiqui-Jain A, Bourbon P, Haddach M, et al. (2011). Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. Journal of Medicinal Chemistry. 54(2), 635–654 doi:10.1021/jm101251q PMID 21174434
  • Siddiqui-Jain, A., Drygin, D., Streiner, N., Chua, P., Pierre, F., O'Brien, S. E., ... & Proffitt, C. (2010). CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer research, 70(24), 10288-10298. PMID 21159648 doi:10.1158/0008-5472.CAN-10-1893
  • Lee, J. Y., Yun, J. S., Kim, W. K., Chun, H. S., Jin, H., Cho, S., & Chang, J. H. (2019). Structural basis for the selective inhibition of Cdc2-like kinases by CX-4945. BioMed research international, 2019. 6125068 doi:10.1155/2019/6125068 PMC 6720368 PMID 31531359
  • Song, C., Gowda, C., Pan, X., Ding, Y., Tong, Y., Tan, B. H., ... & Amin, S. G. (2015). Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood, The Journal of the American Society of Hematology, 126(15), 1813-1822. doi:10.1182/blood-2015-06-651505 PMC 4600018 PMID 26219304
  • Gowda, C., Song, C., Ding, Y., Iyer, S., Dhanyamraju, P. K., McGrath, M., ... & Dovat, S. (2020). Cellular signaling and epigenetic regulation of gene expression in leukemia. Advances in biological regulation, 75, 100665. doi:10.1016/j.jbior.2019.100665 PMC 7239353 PMID 31623972

forbes.ru (Global: 885th place; Russian: 51st place)

nih.gov (Global: 4th place; Russian: 6th place)

ncbi.nlm.nih.gov

  • Pierre F, Chua PC, O'Brien SE, Siddiqui-Jain A, Bourbon P, Haddach M, et al. (2011). Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. Journal of Medicinal Chemistry. 54(2), 635–654 doi:10.1021/jm101251q PMID 21174434
  • Siddiqui-Jain, A., Drygin, D., Streiner, N., Chua, P., Pierre, F., O'Brien, S. E., ... & Proffitt, C. (2010). CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer research, 70(24), 10288-10298. PMID 21159648 doi:10.1158/0008-5472.CAN-10-1893
  • Lee, J. Y., Yun, J. S., Kim, W. K., Chun, H. S., Jin, H., Cho, S., & Chang, J. H. (2019). Structural basis for the selective inhibition of Cdc2-like kinases by CX-4945. BioMed research international, 2019. 6125068 doi:10.1155/2019/6125068 PMC 6720368 PMID 31531359
  • Song, C., Gowda, C., Pan, X., Ding, Y., Tong, Y., Tan, B. H., ... & Amin, S. G. (2015). Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood, The Journal of the American Society of Hematology, 126(15), 1813-1822. doi:10.1182/blood-2015-06-651505 PMC 4600018 PMID 26219304
  • Gowda, C., Song, C., Ding, Y., Iyer, S., Dhanyamraju, P. K., McGrath, M., ... & Dovat, S. (2020). Cellular signaling and epigenetic regulation of gene expression in leukemia. Advances in biological regulation, 75, 100665. doi:10.1016/j.jbior.2019.100665 PMC 7239353 PMID 31623972

web.archive.org (Global: 1st place; Russian: 1st place)